• Part II of Singapore’s “Vaccine Quest”

    Mar 1, 2023, 14:49 PM

  • UK grandmother becomes the first to be inoculated in any mass vaccination programme

    Mar 1, 2023, 14:49 PM

  • More than half the world received at least one dose

    Mar 1, 2023, 14:49 PM

  • Half the world vaccinated against SARS-CoV-2

    Mar 1, 2023, 14:49 PM

  • Singapore unveils the world’s first rapid test for SARS-CoV-2 neutralising antibodies

    Mar 1, 2023, 14:49 PM

  • SARS-CoV-2 is “officially” airborne

    Mar 1, 2023, 14:49 PM

  • Quote- Developing a test fast

    Mar 1, 2023, 14:49 PM

  • Ashley St John: Making sense of immune response research

    Mar 1, 2023, 14:49 PM

  • Mutation unmasks the virus to the immune system

    Mar 1, 2023, 14:49 PM

  • Singapore unveils national preparedness and response programme

    Mar 1, 2023, 14:49 PM

  • Duke-NUS professor among frontliners awarded Singaporean of the Year 2020

    Mar 1, 2023, 14:49 PM

  • A world first: Duke-NUS’ serology test links SARS-CoV-2 clusters

    Mar 1, 2023, 14:49 PM

  • Global death toll rockets past three million

    Mar 1, 2023, 14:49 PM

  • Quote- A world leader in emerging infectious diseases

    Mar 1, 2023, 14:49 PM

  • Study: Many SARS-CoV-2-like coronaviruses lurk in Southeast Asian bats and pangolins

    Mar 1, 2023, 14:49 PM

  • Bringing the intensity and sound of an emergency room online

    Mar 1, 2023, 14:49 PM

  • Quote- Innovating medical education

    Mar 1, 2023, 14:49 PM

  • Inactivated and mRNA vaccines elicit different immune responses

    Mar 1, 2023, 14:49 PM

  • Singapore moves into Phase III of re-opening

    Mar 1, 2023, 14:49 PM

  • Saliva-based rapid test provides hope for sensitive sniffers

    Mar 1, 2023, 14:49 PM
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8